 price
 rais dispel concern
report impress get
concern growth expect came crush
organ rev capital-expenditure environ seem help
along smart sale reorg split sale forc drove
monster instrument mako trend remain healthi placement
util in-line model estimate continu drive knee
hip share gain lastli pipelin remain robust evidenc
manag commentari around camera ramp
remain robust backlog trend new bed launch
manag express confid growth algorithm
rais low high end guid impli top-line
execut within fairli straightforward
provid confid dd ep algorithm pick
coupl item would legaci spine soft lend
credenc spine integr challeng ou knee
soft even segment put subpar
perform perform segment give confid
legitim top-line grower given
rais pt equat price-to-earnings remain
sidelin given limit upsid current valuat level
organ revenue print came whisper expect
price less neg expect
legaci spine soft albeit management reit pf msd outlook
higher volum translat oper leverag get
pass continu make invest support top-line
initi ep level despit lower fx hw
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
rais organ growth
rais ep
omx reiter
acquisit continu prioriti cash use
one extra sell day vs number day
progress gm growth rest year
robot global us robot global us instal base
drive growth hip
mako mean procedur total procedur
signific placement went competit account detail provid
medsurg particularli strong us organ sale growth driven us instrument organ
emerg market call dd gain
price less unfavor expect
rep begin effect cross-sel product
led power tool wast manag product
endoscopi video busi grew dd w/ new camera platform begin ramp
divis sale forc drove out-performance due initi success
bed stretcher product saw strong demand lead strong medic growth
spine neurotech soft msd growth spine off-set soft us neurotech
neurotech boost strong demand cmf neuro-pow instrument product
msd growth spine full year maintain
callout overal neuro soft us
slower organ due sale forc integr
ortho us organ growth ou
strong demand mako tka shoulder implant
emerg market growth call major contributor ou growth
full line obtain shoulder begin drive growth
still us busi current
alpha tibia nail system launch
fx drop affect ep includ translat transact impact
gm boost product off-set price fx mix
om expand driven leverag save off-set invest acquisit impact
tax benefit stock-bas comp
number sell day vs
number sell day well
ytd cash op mm
repurchas common stock
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
articl articl
time dissemin juli
analyst william tong jon bristow vijay kumar primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer
part research analyst compens directli relat specif recommend view research report
